CLARKE JOHN K

SEC source: 0000950170-24-064235 · ownership.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001209191-23-031002 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001209191-23-026069 · doc4.xml · derivative · entry 2

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

F4 · derivative.expiration_date: The RSUs fully vested one year from the grant date which was April 26, 2022.

SEC source: 0001209191-23-026069 · doc4.xml · nonDerivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.

F2 · price: RSUs convert into common stock on a one-for-one basis.

F3 · balance_after: Includes 6,305 shares received as a pro-rata distribution on September 28, 2021 (the "Liquidating Distribution") from CHP II, L.P., in which the Reporting Person is a managing partner. In prior reports, the reporting person reported beneficial ownership of 108,083 shares of aTyr Pharma common stock held by CHP II, L.P., which are no longer held as of September 28, 2021 due to the Liquidating Distribution.

SEC source: 0001209191-22-026084 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001209191-21-035836 · doc4.xml · nonDerivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 108,083

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares were sold to cover fund expenses.

F2 · ownership.nature: These shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.

SEC source: 0001209191-21-029117 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428

Underlying: Common Stock · 1,428 shares

Expires 2031-04-28

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001209191-20-049578 · doc4.xml · nonDerivative · entry 2

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 110,583

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F1 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.

SEC source: 0001209191-20-049578 · doc4.xml · nonDerivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 117,843

F1 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.

SEC source: 0001209191-20-048698 · doc4.xml · nonDerivative · entry 2

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 117,943

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.245, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.

SEC source: 0001209191-20-048698 · doc4.xml · nonDerivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 123,383

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.245 to $4.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose.

SEC source: 0001209191-20-027949 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,428

Underlying: Common Stock · 1,428 shares

Expires 2030-05-06

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001209191-19-029005 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2029-05-08

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001735276-18-000028 · edgardoc.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2028-06-19

SEC source: 0001735276-18-000006 · edgardoc.xml · derivative · entry 6

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.

SEC source: 0001735276-18-000006 · edgardoc.xml · nonDerivative · entry 5

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,891

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.

SEC source: 0001735276-18-000006 · edgardoc.xml · nonDerivative · entry 4

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,991

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.

F4 · price: Sales prices ranged from $100.97 to $101.88.

SEC source: 0001735276-18-000006 · edgardoc.xml · nonDerivative · entry 3

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,091

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.

F3 · price: Sales prices ranged from $99.92 to $100.90.

SEC source: 0001735276-18-000006 · edgardoc.xml · nonDerivative · entry 2

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,133

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.

F2 · price: Sales prices ranged from $98.89 to $99.75.

SEC source: 0001735276-18-000006 · edgardoc.xml · nonDerivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,891

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.

SEC source: 0001209191-18-030884 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2028-05-15

F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 15, 2019 or (ii) the Issuer's 2019 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.

SEC source: 0001553878-17-000022 · edgardoc.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

Underlying: Common Stock · 11,250 shares

Expires 2027-06-01

SEC source: 0001209191-17-031633 · doc4.xml · derivative · entry 1

CLARKE JOHN K · CIK 0001219015 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-05-09

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable on the earlier of (i) May 09, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.